Single-Use Bioreactors Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product Type (Single Use Bioreactor Systems, Media Bags, Filtration Assemblies, Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, Other Cell Types), By Molecule Type (Monoclonal Antibodies, Vaccines, Stem Cells, Gene-modified Cells, Other Molecule Types), By End-User (Pharmaceutical And Biopharmaceutical Industries, Contract Research Organisations, Other End Users), And By Geography - Forecasts From 2022 To 2027

Published:  May 2022 Report Code: KSI061611955 Pages: 114

The single-use bioreactors market is evaluated at US$2.874 billion for the year 2020, growing at a CAGR of 15.82% to reach a market size of US$8.035 billion by the year 2027.

A solitary use bioreactor or single-use bioreactor is a bioreactor with an expendable pack rather than a culture vessel. Regularly, this alludes to a bioreactor in which the fixing in touch with the cell culture will be plastic, and this coating is encased inside a more long-lasting construction, so it is high in demand and more eco-friendly. The expanding pattern toward multi-drug offices demands the creation of various drugs utilizing a similar office, which further raises the demand for single-use bioreactors because of their adaptability in the development of different drugs without compromising the quality of drugs. Increasing research activities and developments in the field of biopharmaceutics are giving potential to the market growth of single-use bioreactors. The flexibility showcased by single-use bioreactors in producing multiple drugs without compromising quality is driving the market value of single-use bioreactors in the medical and biopharmaceutical fields. The reduction in automation complexity offered by single-use bioreactors is also expected to increase the demand for single-use bioreactors among large companies and industries. The policies offered by the governments of several countries in support of research and development in the pharmaceutical and biotechnological fields are also positively influencing the market growth of single-use bioreactors in the global market. The efficiency offered by single-use bioreactors by reducing the costly and time-consuming cleaning process is expected to bolster their demand during the forecast period.

The recent outbreak of the COVID-19 pandemic had a positive impact on the single-use bioreactor market. The impact of the COVID pandemic boosted the research and development activities of the pharmaceutical and medical fields. The need for COVID vaccines in order to prevent the COVID pandemic has fuelled research and development activities in the pharmaceutical and medical fields. The efficiency showcased by single-use bioreactors in manufacturing multiple drugs without compromising quality increased the market demand for single-use bioreactors in the COVID pandemic period. The need for less time-consuming and more effective bioreactors for spontaneous and rapid vaccine research development programs drove the market demand for single-use bioreactors during the pandemic period.

Biopharmaceutical Research and Development is on the rise. The interest in biopharmaceuticals is expanding worldwide because of the growing geriatric population percentage, as this population is more susceptible to a wide scope of infections. Looking at the increasing opportunities, worldwide organizations and major companies are investing more in biopharmaceutical research and development programs. When compared to other assembling ventures, the biopharmaceutical industry contributes many times more in terms of research and development.  According to the reports of the FIP (International Pharmaceutical Federation) in 2018, the world’s biopharmaceutical organizations had collectively invested about 102 billion USD in research and development programs. Single-use bioreactors are a vital piece of the biopharmaceutical component producing work processes. They make up an enormous level of small and mid-scale biopharmaceutical manufacturing, especially in clinical testing and innovative work. Because of the benefits of single-use bioreactors over traditional biomanufacturing strategies, their popularity has expanded in biopharmaceutical research and development. The increasing research and development programs are considered a positive sign for the growth of the single-use bioreactor market.

The flexibility offered by Single-Use Bioreactors

The flexibility offered by single-use bioreactors is another major factor positively driving the market growth of the single-use bioreactor market. The efficiency showcased by single-use bioreactors in manufacturing different types of drugs and assisting different biopharmaceutical processes is increasing the application of single-use bioreactors in various fields. The large investments of major companies in developing single-use bioreactors compared to conventional ones are significantly boosting the growth of the global single-use bioreactor market. 

North America is the market leader. Geographically, the North American region is estimated to hold the lion's share of the single-use bioreactor market. The presence of well-established medical and pharmaceutical infrastructure in the North American countries and the presence of major players are some of the prominent reasons behind the large market share of the North American region in the single-use bioreactor market.

Single-Use Bioreactors Market Scope:

Report Metric Details
 Market size value in 2020  US$2.874 billion
 Market size value in 2027  US$8.035 billion
 Growth Rate  CAGR of 15.82% from 2020 to 2027
 Base year  2020
 Forecast period  2022–2027
 Forecast Unit (Value)  USD Billion
 Segments covered  Product Type, Cell Type, Molecule Type, End-User, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered ABEC Inc., Celltainer, Distek Inc., Eppendorf AG, GE Healthcare, Thermo Fisher Scientific, Parker Hannifin, Danaher, PBS Biotech, Cellexus, Applikon Biotechnology
 Customization scope  Free report customization with purchase

 

Market Segmentation

  • By Product Type
    • Single-Use Bioreactor Systems
    • Media Bags
    • Filtration Assemblies
    • Other Products
  • By Cell Type
    • Mammalian cell
    • Bacteria
    • Yeast
    • Other Cell Types
  • By Molecule Type
    • Monoclonal Antibodies
    • Vaccines
    • Stem Cells
    • Gene-modified Cells
    • Other Molecule Types
  • By End-User
    • Pharmaceutical and Biopharmaceutical industries
    • Contract Research Organisations
    • Other End Users
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • UK
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the single-use bioreactors market size by 2027?
A1. The single-use bioreactors market is projected to reach a market size of US$2.874 billion by 2027. 


Q2. What are the growth prospects for the single-use bioreactors market?
A2. The global single-use bioreactors market is projected to grow at a CAGR of 15.82% during the forecast period. 


Q3. What is the size of the global single-use bioreactors market?
A3. Single-Use Bioreactors Market was valued at US$8.035 billion in 2020. 


Q4. What factors are anticipated to drive the single-use bioreactors market growth?
A4. Increasing research activities and developments in the field of biopharmaceutics are giving potential to the single-use bioreactors market growth.


Q5. Which region holds the maximum market share in the single-use bioreactors market?
A5. Geographically, the North American region is estimated to hold the lion's share of the single-use bioreactor market owing to the presence of well-established medical and pharmaceutical infrastructure in the region.

1. Introduction
1.1. Market Definition
1.2. Market Segmentation


2. Research Methodology
2.1. Research Data
2.2. Assumptions


3. Executive Summary
3.1. Research Highlights


4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis


5. Single-Use Bioreactors Market Analysis, by Product Type
5.1. Introduction
5.2. Single-Use Bioreactor Systems
5.3. Media Bags
5.4. Filtration Assemblies 
5.5. Other Products 


6. Single-Use Bioreactors Market Analysis, by Cell Type
6.1. Introduction
6.2. Mammalian cell
6.3. Bacteria
6.4. Yeast
6.5. Other Cell Types


7. Single-Use Bioreactors Market Analysis, by Molecule Type
7.1. Introduction
7.2. Monoclonal Antibodies
7.3. Vaccines
7.4. Stem cells
7.5. Gene-modified Cells
7.6. Other Molecule Types

8.  Single-Use Bioreactors Market Analysis, by End Users
8.1.  Introduction
8.2. Pharmaceutical and Biopharmaceutical industries
8.3. Contract Research Organizations
8.4. Other End Users


9. Single-Use Bioreactors Market Analysis, by Geography
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. UK
9.4.4. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Taiwan
9.6.6. Thailand
9.6.7. Indonesia
9.6.8. Others


10. Competitive Environment and Analysis
10.1. Major Players and Strategy Analysis
10.2. Emerging Players and Market Lucrativeness
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Vendor Competitiveness Matrix

11. Company Profiles 
11.1. ABEC Inc.
11.2. Celltainer
11.3. Distek Inc.
11.4. Eppendorf AG
11.5. GE Healthcare
11.6. Thermo Fisher Scientific
11.7. Parker Hannifin
11.8. Danaher
11.9. PBS Biotech 
11.10. Cellexus 
11.11. Applikon Biotechnology

ABEC Inc.

Celltainer

Distek Inc.

Eppendorf AG

GE Healthcare

Thermo Fisher Scientific

Parker Hannifin

Danaher

PBS Biotech

Cellexus

Applikon Biotechnology

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us